FindTrial
Sign In

Clinical evaluation of MÄ?tuḷai Ney in the management of Childhood Asthma.

Clinical evaluation of the effect on oral administration of MÄ?tuḷai Ney in the management of CÅ«li Kaá¹?am.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/030934
Enrollment
40
Registered
2021-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: MÄ?tuḷai Ney: It is an internal medicine and it is administered 5- 10 ml twice a day Control Intervention1: nil: nil

Sponsors

N Prabhavathi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Cough with or without expectoration Wheezing Tightness of chest Difficult in breathing Rhinitis mild fever loss of appetite

Exclusion criteria

Exclusion criteria: cough with hemoptysis high grade fever wheeze that are present in other respiratory ailments congenital heart disease/cardiac asthma dyspnoea associated with cyanosis and clubbing pneumonia

Design outcomes

Primary

MeasureTime frame
reduction in the symptoms like difficulty in breathing cough with or without expectoration fever and loss of appetiteTimepoint: 10 days—

Secondary

MeasureTime frame
reduction of symptoms like tightness of chest wheeze sounds and reduction in absolute eosinophil count and changes in the chest x rayTimepoint: 40 days—

Countries

India

Contacts

Public ContactK Shyamala

Government Siddha Medical College and Hospital, Palayamkottai

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026